Silvy Laporte
Saint-etienne-de-valoux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Chlorhexidine or Povidone-Iodine for CIED Procedures? Lessons From CHLOVIS and WRAP-IT.
Journal: Pacing and clinical electrophysiology : PACE
Published: July 30, 2026
Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project.
Journal: Thrombosis and haemostasis
Published: July 14, 2026
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.
Journal: Circulation
Published: July 13, 2026
API-CAT Investigators' Decisions on Anticoagulation following Extended Treatment for Cancer VTE.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: May 23, 2026
Enoxaparin for the treatment of placenta-derived fetal growth restriction (GROWTH): an open-label multicenter randomized trial.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 03, 2026
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated VTE - Authors' reply.
Journal: The Lancet. Haematology
Published: February 05, 2026
The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis.
Journal: Research and practice in thrombosis and haemostasis
Published: September 16, 2025
Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study.
Journal: Journal of the American College of Cardiology
Published: August 26, 2025
Apixaban for Cancer-Associated Venous Thromboembolism. Reply.
Journal: The New England journal of medicine
Published: July 17, 2025
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial.
Journal: The Lancet. Haematology
Published: May 13, 2025
Last Updated: 09/26/2026